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Beauvericin, a cyclohexadepsipeptide ionophore
from the entomopathogen Beauveria bassiana,
shows antibiotic, antifungal, insecticidal, and cancer
cell antiproliferative and antihaptotactic (cell motility
inhibitory) activity in vitro. The bbBeas gene encod-
ing the BbBEAS nonribosomal peptide synthetase
was isolated from B. bassiana and confirmed to be
responsible for beauvericin biosynthesis by targeted
disruption. BbBEAS utilizes D-2-hydroxyisovalerate
(D-Hiv) and L-phenylalanine (Phe) for the iterative
synthesis of a predicted N-methyl-dipeptidol inter-
mediate, and forms the cyclic trimeric ester beauver-
icin from this intermediate in an unusual recursive
process. Heterologous expression of the bbBeas
gene in Escherichia coli to produce the 3189 amino
acid, 351.9 kDa BbBEAS enzyme provided a strain
proficient in beauvericin biosynthesis. Comparative
infection assays with a BbBEAS knockout B. bassi-
ana strain against three insect hosts revealed that
beauvericin plays a highly significant but not indis-
pensable role in virulence.
INTRODUCTION
Beauvericin is a cyclooligomer depsipeptide ionophore that
transports monovalent cations across membranes as a free
carrier uncoupling oxidative phosphorylation (Steinrauf, 1985).
Beauvericin displays a diverse array of biological activities
in vitro. It shows moderate antifungal and antibiotic activity
(Hamill et al., 1969), and potentiates other antifungal agents in
combination therapies (Zhang et al., 2007). Importantly, beau-
vericin displays a broad-spectrum antiproliferative activity
against different human cancer cell lines by activating calcium-
sensitive cell apoptotic pathways (Jow et al., 2004). It also inhibits
the directional cell motility (haptotaxis) of cancer cells at subcyto-
toxic concentrations (Zhan et al., 2007): haptotaxis is essential
for the formation of new blood vessels in tumors (angiogenesis),
invasion of other tissues by cancer cells, andmetastasis (Carme-
liet, 2003).898 Chemistry & Biology 15, 898–907, September 22, 2008 ª2008 EBeauveria (teleomorph: Cordyceps) bassiana (Hypocreales) is
a broad host range facultative entomopathogen that plays an im-
portant role in the control of insect populations in nature. During
its pathogenic phase, the developing hyphae of B. bassiana di-
rectly penetrate the insect integument by producing extracellular
enzymes (Fan et al., 2007). Virulence factors that modulate the
insect immune system, and those that disable and finally kill
the host, are also expected to contribute to the pathogenic arma-
mentarium of B. bassiana. Filamentous fungi with a pathogenic
lifestyle often produce a large variety of polyketide and nonribo-
somal peptide natural products that act as immunosuppressors,
and general or host-specific toxins (von Do¨hren, 2004). Thus,
B. bassiana produces the cyclooligomer nonribosomal depsi-
peptides beauvericin and bassianolide, the diketomorpholine
bassiatin, the cyclic peptides beauverolides, the dibenzoqui-
none oosporein, and the 2-pyridone tenellin (Figure 1). Tenellin,
a polyketide nonribosomal peptide, was shown not to be in-
volved in insect pathogenesis (Eley et al., 2007). Confirming ear-
lier reports on the in vitro toxicity of bassianolide to insects
(Champlin and Grula, 1979), we have recently shown that a bas-
sianolide-nonproducer strain of B. bassiana is significantly less
virulent against selected insect hosts (unpublished data). How-
ever, the in vivo significance of beauvericin for the producer
organism has remained controversial up to now, as purified
beauvericin was shown to be toxic only to some insect larvae
(Champlin and Grula, 1979; Hamill et al., 1969).
Nonribosomal peptides are assembled in a process of step-
wise condensations on nonribosomal peptide synthetases
(NRPSs). Incorporation of each precursor into the product
requires a separate NRPS module, with each module featuring
enzymatic domains for the activation (A: adenylation domain),
covalent thioester tethering (T: thiolation domain), and conden-
sation (C domain) of the precursors (Finking and Marahiel,
2004). Further domains in the NRPS modules might edit the
enzyme-bound precursors or intermediates. The product is re-
leased (and cyclized, if necessary) by a penultimate TE (thioes-
terase), R (reductase), or C domain (Kopp and Marahiel, 2007).
According to the classical NRPS paradigm, each module and
each active site domain is used only once during product as-
sembly (Finking and Marahiel, 2004). By contrast, NRPSs that
synthesize cyclooligomer peptides assemble oligopeptide
monomer intermediates by the programmed iterative use of
their modules. These monomers are then used in a recursivelsevier Ltd All rights reserved
Chemistry & Biology
Beauvericin Biosynthesisoligomerization and cyclization process (Kopp and Marahiel,
2007). NRPSs that synthesize depsipeptides incorporate 2-
hydroxycarboxylic acids into their products, and may form ester
instead of amide bonds.
An impressive series of publications from the Zocher lab
describe the cloning and enzymatic characterization of the
cyclooligomer depsipeptide synthetase (CODS) for enniatin bio-
synthesis from Fusarium equiseti (synonym: F. scirpi) (Glinski
et al., 2002; Hacker et al., 2000; Haese et al., 1993; Hornbogen
et al., 2007; Krause et al., 2001; Pieper et al., 1995). Although
the beauvericin synthetase has also been purified from B. bassi-
ana (Peeters et al., 1988), the encoding gene has hitherto not
been identified. In the present study, we have cloned the NRPS-
encoding gene for the beauvericin synthetase of B. bassiana.
Targeted inactivation of this gene allowed the evaluation of the
in vivo role of beauvericin in insect pathogenesis. A highly effi-
cient heterologous production system was also developed by
the expression of the beauvericin synthetase in an apparently
functional form in Escherichia coli.
RESULTS
Isolation of the Beauvericin Biosynthetic Locus
We have used several different pairs of PCR primers for the se-
lective amplification of NRPS gene segments from B. bassiana
genomic DNA. Because the beauvericin synthetase was ex-
pected to activate D-2-hydroxyisovalerate (D-Hiv), we sought
increased selectivity by designing two primer sets to amplify
A-domain-encoding sequences with high similarity to the D-Hiv-
activating A1 domain of the ESYN enniatin synthetase from
F. equiseti (GenBank accession number CAA79245). Two dis-
tinct amplification products from reactions with the EA1f-EA1r
primer pair, EA1042 and EA1046, were indeed found to encode
A-domain segments highly similar (64.6% and 69.7% identity,
respectively) to the A1 domain of ESYN. As all the other amplified
sequences were significantly less similar to ESYN, we expected
EA1042 and EA1046 to represent those NRPS A domains that
Figure 1. Secondary Metabolites of B.
bassiana
The structures of enniatins from Fusarium sp. and
a generalized structure of the dipeptidol monomer
intermediate are shown.
might activate D-Hiv. EA1042 was later
found to be derived from the bbBsls
gene encoding the bassianolide synthe-
tase of B. bassiana (unpublished data).
This report describes the characteriza-
tion of the EA1046-related NRPS as the
beauvericin synthetase.
First, we sought proof that the EA1046-
related mRNA is present in B. bassiana
cells under beauvericin production con-
ditions. We have used RT-PCR with
a primer pair specific for the EA1046
(but not the EA1042) sequence and total
RNA from beauvericin-producing cul-
tures, and observed the specific amplification of the expected
product (results not shown). Next, we have isolated the
EA1046-related locus froma genomic DNA library ofB. bassiana.
Fosmids hybridizing with EA1046 as the probe did not overlap
with those hybridizing with EA1042, proving that the two ampli-
fication products originated from distinct genomic loci. Two rep-
resentative EA1046-homologous fosmids were sequenced to
yield a 33,475 bp contig (Figure 2) centered on a 9,570 bp
gene (bbBeas) encoding a putative CODS. The contig contains
a further nine open reading frames, three of which encode puta-
tive carboxylic acid oxidoreductases related to branched-chain
amino acid catabolism (Table 1). Thus, the kivr gene encodes
a novel NADPH-dependent 2-ketoisovalerate reductase (KIVR)
proposed to convert 2-ketoisovalerate from valine catabolism
or pyruvate metabolism to D-Hiv (Figure 2). Disruption of kivr
abolishes the biosynthesis of beauvericin and bassianolide,
and cyclodepsipeptide production can be rescued by comple-
mentation with D-Hiv (unpublished data). The translation of the
predicted pseudogene orf4 would yield an N- and C-terminally
truncated protein segment with high similarity to glycolate oxi-
dases and lactatemonooxygenases. Oxidizing short-chain 2-hy-
droxycarboxylic acids, such an enzyme might have interfered
with beauvericin production by depleting D-Hiv. Downstream
of the NRPS-encoding gene, orf7 codes for a putative methyl-
malonate semialdehyde dehydrogenase, another enzyme from
valine catabolism. At the left border of the sequenced region,
orf1 encodes a putative Gal4-like transcriptional regulator with
a Zn2Cys6 binuclear cluster DNA-binding domain. Similar regula-
tors are often encoded in secondary metabolite biosynthetic
gene clusters of fungi (Bergmann et al., 2007). Three conserved
hypothetical proteins (ORF3, ORF5, and ORF8) and two de-
duced proteins that might be involved in protein folding (ORF2
and ORF6) are also encoded in the sequenced locus.
Disruption of the bbBeas Gene in B. bassiana
To ascertain the function of the CODS encoded by bbBeas, an
internal fragment of this gene on the B. bassiana genome was
Chemistry & Biology 15, 898–907, September 22, 2008 ª2008 Elsevier Ltd All rights reserved 899
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rium-mediated transformation (Fang et al., 2004). Approximately
15% of the glufosinate-resistant progeny were found to originate
from double homologous recombination (Figures 3A–3C). The
isolates with the disrupted bbBeas gene showed unchanged
growth rates and morphology. LC-MS analysis of fermentation
extracts of wild-type B. bassiana and several ectopic integrant
isolates revealed copious production of beauvericin and bassia-
nolide. However, beauvericin production was specifically and
completely arrested in all bbBeas knockout isolates, with a con-
comitant slight increase of bassianolide production (Figure 3D).
Thus, the bbBeas-encoded CODS is responsible for the bio-
synthesis of beauvericin inB. bassiana, but not for that of bassia-
nolide.
Comparative Sequence Analysis of the Beauvericin
Synthetase
The bbBeas gene encodes a predicted NRPS (BbBEAS) of 3,189
amino acids in length. The deduced molecular mass of BbBEAS
(351,889 Da) is about 100 kDamore than earlier estimates for the
purified beauvericin synthetase (Peeters et al., 1988); a discrep-
ancy of identical magnitude was noted for the initial size esti-
mates versus the deduced size of the ESYN enniatin synthetase
(Haese et al., 1993; Pieper et al., 1995). BbBEAS shows 60%
identity and 75% similarity to ESYN (GenBank accession num-
ber CAA79245), and 65% identity and 79% similarity to the
BbBSLS bassianolide synthetase ofB. bassiana ATCC 7159 (un-
published data). A similar level of identity is also noted with the
NRPS-homologous part of the bassianolide synthetase of Xylaria
sp. BCC 1067 (GenBank accession number ABR28366), whose
characterization coincided with our work (Jirakkakul et al., 2008).
Regardless of synthesizing hexa- or octadepsipeptides, all these
CODSs feature identical module and domain organizations:
C1A1T1-C2A2M2T2aT2b-C3 (Figure 2). The A1 domains within the
first modules of the beauvericin, bassianolide, and enniatin
synthetases are all expected to activate D-Hiv as an adenylate
and install it as a thioester onto the T1 domains of the samemod-
ules, as demonstrated for ESYN (Haese et al., 1994; Pieper et al.,
Figure 2. The bbBeas Locus and Proposed
Biosynthesis of Beauvericin
(A) Putative open reading frames (see Table 1) are
shown as white arrows, the bbBeas and kivr genes
are drawn as black arrows, the two sequenced
fosmids are indicated as two-way gray arrows,
and the approximate position of the EA1046 PCR
product is shown as a bold line.
(B) Model of the biosynthesis of beauvericin from
primary metabolites on the BbBEAS beauvericin
synthetase (domains not to scale).
1995). The enniatin and the bassianolide
synthetase A2 domains activate and
load branched-chain amino acids onto
the twin T2 domains within module 2. In
contrast, the BbBEAS beauvericin syn-
thetase A2 domain was shown to be spe-
cific for Phe (Peeters et al., 1988; Xu et al.,
2007). The amino acid constituents of
fungal cyclooligomer depsipeptides are all modified by N-meth-
ylation, accomplished at the amino acyl thioester stage by SAM-
dependent N-methyltransferase domains in NRPSs (Billich and
Zocher, 1987; Hacker et al., 2000). Indeed, integrated N-methyl-
transferase domains responsible for this editing function were
first identified from the enniatin and the beauvericin synthetases
(Billich and Zocher, 1987; Peeters et al., 1988). The N-methyl-
transferase domains (M2) of the CODSs display three well-con-
served core motifs (Schwarzer et al., 2003), and are inserted
into a flexible loop region between core motifs 8 and 9 of the
A2 domains (Figure 2). This ‘‘stuffer’’ region often accommodates
different ‘‘editing’’ domains in diverse NRPSs. Dipeptidol forma-
tion from D-Hiv and the N-Me-amino acid, both presented as
thioesters on the phosphopantetheinyl arms of T domains, is cat-
alyzed by the condensation domain C2 in CODSs (Figure 2). The
beauvericin, bassianolide, and enniatin synthetases also feature
both an N-terminal C1 and a C-terminal C3 domain each that
might play a role in the recursive cyclooligomerization process
characteristic of fungal CODS (Glinski et al., 2002; Haese et al.,
1993). The C1 and C3 domains show overall similarity to conden-
sation domains, but their core motifs are substantially divergent
from the canonical forms (Schwarzer et al., 2003). However, they
retain a modified form of the active site signature (SHxxVD in C1
and SHALYDG in C3 domains versus HHxxxDG for the canonical
motif) incorporating the His active site and the conserved Asp
that stabilizes the active site architecture.
Heterologous Production of Beauvericin in E. coli
Expression of active fragments of ESYN have been demon-
strated using E. coli and Saccharomyces cerevisiae as hosts
(Billich and Zocher, 1987; Hornbogen et al., 2007), but the heter-
ologous expression of a fungal CODS in a functional form has
hitherto not been reported. We have used the T7 promoter-
based dual expression vector pACYCDuet-1 for the coregulated
expression of the intronless bbBeas gene with the phosphopan-
tetheinyl transferase-encoding gene sfp from Bacillus subtilis
(Quadri et al., 1998). The resulting expression construct (Figure 4)
was introduced into several E. coli expression hosts and used for
900 Chemistry & Biology 15, 898–907, September 22, 2008 ª2008 Elsevier Ltd All rights reserved
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Beauvericin BiosynthesisTable 1. Databank Similarities of the Deduced Proteins from the Beauvericin Locus
Gene Models
(Start–end, bp)
Protein
Length (aa)
Closest GenBank
Homolog, Organism,a
Function of the Homolog
Identity/
Similarity (%) Conserved Domain E Valueb
orf1c (1–2,705) 749 XP_001556512,
B. fuckeliana,
hypothetical protein
37/54d cd00067, GAL4-like
Zn2Cys6 binuclear cluster
DNA-binding domain
2e07
orf2c (3,519–5,598) 623 XP_380656,
G. zeae, cyclophilin
with WD40 domain
79/90 cd01927, cyclophilin-type
peptidyl-prolyl cis-trans
isomerase; and cd00200,
WD40 domain
2e72
1e19
orf3 (6,216–6,956) 228 XP_380657, G. zeae,
hypothetical protein
56/75 pfam04750, FAR-17a/
AIG1-like protein
0.002
orf4c,e (7,041–7,751) NAe XP_001823913,
A. oryzae, glycolate oxidase
47/66e cd03332, L-lactate
2-monooxygenase
FMN-binding domain
3e63
kivrc (7,882–9,270) 462 XP_382715, G. zeae,
ketopantoate reductase
43/61 PRK06522, 2-ketopantoate
reductase
7e21
bbBeas (11,511–21,080) 3189 CAA79245, F. equiseti,
enniatin nonribosomal
peptide synthetase
60/75
orf5 (23,275–24,112) 212 XP_380668, G. zeae,
hypothetical protein
38/57 ND NA
orf6 (25,822–27,691) 557 XP_380667, G. zeae,
calreticulin
75/86 pfam00262,
calreticulin family
2e113
orf7 (28,615–30,425) 584 EAA35465, N. crassa,
methylmalonate
semialdehyde
dehydrogenase
81/90 pfam00171, aldehyde
dehydrogenase family
3e120
orf8 (31,637–33,475) 612 EAQ93245, C. globosum,
hypothetical protein
30/40d ND NA
NA, not applicable; ND, not detected.
aGenus abbreviations: A, Aspergillus; B, Botryotinia; C, Chaetomium; F, Fusarium; G, Gibberella; N, Neurospora.
b E value for the match against the conserved domain.
c Reverse complement.
d Similarity on a shorter protein segment only.
e Predicted pseudogene. Identity and similarity percentages are from the deduced protein sequence regardless of internal stop codons.the biocatalytic conversion of D-Hiv to beauvericin. Low-level
production (0.1 mg/l of expression culture) of a substance comi-
grating with beauvericin was detected with BL21(DE3) as the
host and protein expression at 20C. No product was formed
with expression cultures above 25C, or without supplementa-
tion with D-Hiv (E. coli is not known to produce this metabolite).
Heterologous production of beauvericin was improved by utiliz-
ing E. coli Origami B(DE3): this host facilitates proper protein
folding by promoting cytoplasmic disulfide bond formation.
Further improvement was gained by reducing the cultivation
temperature to 16C, supplementing L-Phe to the bioconver-
sions, and increasing the length of the reaction to 48 hr. The iden-
tity of the isolated product was confirmed by detecting the
appropriate molecular ion in high-resolution mass spectrometry
(Figure 4). The biocatalytic conversion of D-Hiv and L-Phe to fully
elaborated beauvericin shows that BbBEAS is functional in
E. coli. Further, the yield of beauvericin with E. coli reached ap-
proximately 8 mg/l of expression culture, around 40% of that
with B. bassiana (approximately 20 mg/l).Chemistry & Biology 15, 898–9Beauvericin Is a Virulence Factor of B. bassiana
We have compared the virulence of B. bassiana ATCC 7159
(wild-type) with the bbBeas KO beauvericin synthetase knock-
out strain and the kivr KO knockout strain (the latter is deficient
in both beauvericin and bassianolide production owing to the
specific disruption of the 2-ketoisovalerate reductase-encoding
gene). Last-instar larvae of the greater wax moth Galleria mello-
nella, the corn earworm Helicoverpa zea, and the fall armyworm
Spodoptera exiguawere used as insect hosts.G.mellonellawas
selected considering its previous use for the evaluation of tenel-
lin as a virulence factor in B. bassiana (Eley et al., 2007). Spo-
doptera cells were found to be sensitive to beauvericin in vitro
(Fornelli et al., 2004), whereas H. zea was described to be
resistant to purified beauvericin but sensitive to bassianolide
(Champlin and Grula, 1979). Gratifyingly, larval mortality was
significantly reduced (p < 0.05) when comparing the mutant
B. bassiana strains to the wild-type in all three insect hosts
(Figure 5). The highest cumulative mortality was observed in
S. exigua challenged with the wild-type strain at a dose of07, September 22, 2008 ª2008 Elsevier Ltd All rights reserved 901
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Beauvericin Biosynthesis1 3 106 conidia/ml (98.1% ± 2.5, day 7). Wild-type B. bassiana
was also highly virulent against G. mellonella, with H. zea show-
ing the most resistance to this fungus. By contrast, both mutant
strains exhibited very low virulence against all three insects even
at the highest dose (Figure 5), irrespective of the previously
described sensitivity or resistance of these hosts to purified
beauvericin. Clear signs of fungal infection and subsequent
mortality were delayed with both mutants in all hosts. However,
there was no clear tendency for decreased mortality of the in-
sects challenged with the strain deficient in the production of
both beauvericin and bassianolide (kivr KO) as compared to
the beauvericin-nonproducer mutant.
DISCUSSION
The synthesis of cyclooligomer depsipeptides by both filamen-
tous fungi and bacteria significantly deviates from the collinear
and processive logic of canonical NRPSs (Schwarzer et al.,
2003; von Do¨hren, 2004). Thus, CODSs execute a parallel syn-
thetic scheme that involves the programmed iterative synthesis
of peptidol monomer intermediates from amino acid and
2-hydroxycarboxylic acid precursors (Figure 2). The monomers
undergo recursive ligations and macrolactone ring closure in
a concerted, ester bond-forming cyclooligomerization process.
Bacterial CODSs hold the first monomer unit on their TE domain
Figure 3. Insertional Inactivation of the
bbBeas Gene
(A) Scheme for the double homologous recombi-
nation between the T-DNA and the B. bassiana
genome. LB and RB, left and right borders of the
T-DNA; B, BamHI restriction site; X, XhoI restric-
tion site.
(B) Southern hybridization against XhoI-digested
total DNA of several transformants. The arrows
show the expected hybridizing fragment found in
isolates 3, 6, and 9. M, marker.
(C) Southern hybridization against BamHI-
digested total DNA preparations of selected
isolates from (B). The arrow shows the expected
hybridizing fragment.
(D) Cyclooligomer depsipeptide production in
B. bassianaATCC7159 (wild-type) and thebbBeas
knockout mutant (bbBeas KO). *, the expected
position of the beauvericin peak (absent).
Figure 4. Heterologous Production of
Beauvericin
(A–D) HPLC traces of (A) authentic beauvericin
isolated from B. bassiana fermentations; (B) an or-
ganic extract of E. coli Origami B(DE3) [pACYC-
Duet-1] biotransformation reaction with D-Hiv
and L-Phe; (C) an organic extract of E. coli
BL21(DE3) [pACYC-bbBeas-sfp] 20 hr biotrans-
formation reaction with D-Hiv; and (D) an organic
extract of E. coli Origami B(DE3) [pACYC-
bbBeas-sfp] 48 hr biotransformation reaction
with D-Hiv and L-Phe. The arrows indicate the
beauvericin peak; absence of this peak is empha-
sized with an asterisk.
(E) Schematic representation of the expression
cassette in pACYC-bbBeas-sfp.
(F) FTICR-MS spectrum of beauvericin isolated
from the extract of the reaction shown in (D).
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catalyzed by this recursive TE domain in cooperation with the
preceding T domain (Kopp andMarahiel, 2007). Cyclooligomeri-
zation has probably evolved independently in fungal NRPSs. In-
stead of TE domains, these CODSs feature two characteristic
domains at their N and C termini (the C1 and C3 domains, re-
spectively) both with overall similarity to condensation domains,
and also feature two consecutive T domains within their second
modules. Zocher and colleagues proposed (Glinski et al., 2002;
Haese et al., 1993) that one dipeptidol monomer is transiently
parked on one of the two T2 domains while a second dipeptidol
is assembled on the other. These monomers would then be li-
gated and cyclized by the C1 and C3 domains (Figure 2). Thus,
the C1 and/or the C3 domains should function as recursive
condensation catalysts that form both inter- and intramolecular
ester bonds. Fittingly, the C3 domains of the fungal CODSs are
most similar to terminal C domains that catalyze product re-
lease by intramolecular cyclization in other fungal NRPSs
such as the Tolypocladium inflatum cyclosporine synthetase
(GenBank accession number CAA82227, 42% identity/61%
similarity to the C3 domain of BbBEAS). However, the C1
domains of the fungal CODSs have no close (>30% identity)
database homologs. The C1 and C3 domains feature slightly
modified active site signatures (SHxxVD in C1 and SHALYDG
in C3 domains). The BbBEAS C1 domain is even more irregular
in missing the His that is essential for condensation catalysis
(HLxxxD, compared to the C domain consensus HHxxxD).
Similar mutations were previously shown to inactivate conden-
sation domains (Bergendahl et al., 2002). However, this change
should have no effect on the function of the C1 domain of
BbBEAS, considering that this is the only synthetase for beau-
vericin production in B. bassiana, and that beauvericin produc-
tion can be reconstituted in E. coli using the bbBeas gene. Thus,
C1 domainsmight indeed serve a function different from peptide
bond formation. As of now, however, there is no experimental
evidence for the role of either the C1 or the C3 domains in fungal
cyclodepsipeptide synthesis.
Figure 5. Virulence of B. bassiana Strains
Against Selected Insects
(A) Time course of the survival of G. mellonella,
S.exigua, andH.zea larvae infectedwithB.bassiana
at 106 conidia/ml. Squares, B. bassiana ATCC
7159 wild-type; circles, beauvericin-nonproducer
strain bbBeas KO; triangles, beauvericin and bas-
sianolide-nonproducer strain kivr KO.
(B) Endpoint survival assays. Significantly different
means of survival (p < 0.05) for a given insect chal-
lengedwith the three fungal strains at a given conid-
ial suspension concentration are emphasized with
different superscript letters. Error bars and values
signify standard deviations.
The structurally related cyclooligomer
depsipeptides of Sordariomycetes might
be classified according to their oligomer-
ization state: hexadepsipeptides like
beauvericin and enniatin are assembled
from three dipeptidol monomers; octa-
depsipeptides like bassianolide are formed from fourmonomers;
and diketomorpholines like bassiatin correspond to a single
monomer (Figure 1). Comparisons of the primary amino acid se-
quences of the corresponding synthetases, or separately their
C1 or C3 domains, failed to provide any sequence clues for the
programming of the number of ligations during cyclooligomeri-
zation. Similarly, it is currently not possible to predict product
chain length from the primary amino acid sequences of other
iterative enzymes like bacterial type II polyketide synthases
(PKSs), fungal PKSs, or type III polyketide (chalcone) synthases.
Chain length (oligomerization state) is probably determined by
the shape and size of the active site cavities where condensation
or cyclooligomerization occurs.
The biosynthesis of 2-hydroxycarboxylate precursors in bac-
teria and fungi may represent another example of convergent
evolution. Bacterial depsipeptide synthetases employ A do-
mains that load 2-ketocarboxylates as b-ketoacyl thioesters
onto their cognate T domains, and use chiral ketoacyl reductase
domains for the in situ synthesis of 2-hydroxycarboxylate thio-
esters (Fujimori et al., 2007; Magarvey et al., 2006). In contrast
to this on-demand strategy, fungal CODS A domains utilize
free 2-hydroxycarboxylates, preformed by chiral, dissociated,
monofunctional, NADPH-dependent enzymes (Lee et al., 1992;
Pieper et al., 1995). Thus, the 2-ketoisovalerate reductase of B.
bassiana, whose encoding gene, kivr, is clustered with bbBeas,
produces D-Hiv that is proposed to be activated by the A1 do-
mains of both the beauvericin and the bassianolide synthetases
inB. bassiana.While thismanuscript was in preparation, a reduc-
tase domain similar to KIVR has been found appended to the C
terminus of the Xylaria sp. bassianolide synthetase (Jirakkakul
et al., 2008).
Previous work has shown that the amino acids that line the ac-
tive site cavities of bacterial A domains can be reliably predicted
using sequence alignments with two structurally characterized A
domains as the anchors. Further, the derived 10 amino acid ‘‘sig-
natures’’ can be used for the a priori prediction of the substrate
specificities of bacterial A domains (Challis et al., 2000;
Chemistry & Biology 15, 898–907, September 22, 2008 ª2008 Elsevier Ltd All rights reserved 903
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Beauvericin BiosynthesisTable 2. Specificity-Conferring Signatures of NRPS Adenylation Domains
Synthetasea Domain Specificityb 235c 236 239 278 299 301 322 330 331 517
BbBEAS A1 D-Hiv G A L M I V G S I K
BbBSLS A1 D-Hiv G A L M V V G S I K
XsBSLS A1 D-Hiv G A L L V V G T I K
FeESYN A1 D-Hiv G A L H V V G S I K
Proposed fungal D-Hiv signature G A L x I/V V G S/T I K
StVlm1 A1 Kiv A A L W I A V S G K
BcCesB A1 Kiv V G F W V A V S D K
KsKtzG A Kiv V T Y F N G P S G K
Bacterial Phe signature D A W T I A A V C K
BbBEAS A2 Phe D G Y I M A A V M K
AfPSES A1 Phe D A Y T M A A I C K
CpEALS A2 Phe D L V G M A A V G K
AfGliP A2 Phe D Y N T Y T A I C K
BbBSLS A2 Leu D G Y I I G G V F K
XsBSLS A2 Leu D A W L V G A V M K
FeESYN A2 V(LI) D G W F I G I I I K
FsESYN A2 I(LV) D G W F A G V M I K
Amino acids identical to those in the A-domain signatures of BbBEAS are shown in white font on a black background. Amino acids similar (V = I = L,
A = G, S = T, W = Y = F) to those in the A-domain signatures of BbBEAS are shown in bold type.
a NRPS abbreviations (and GenBank accession numbers): BbBSLS, B. bassiana bassianolide synthetase (unpublished data); XsBSLS, Xylaria
sp. bassianolide synthetase (ABR28366); FeESYN, F. equiseti enniatin synthetase (CAA79245); StVlm1, Streptomyces tsusimaensis valinomycin
synthetase subunit 1 (ABF61888); BcCesB, Bacillus cereus cereulide synthetase B subunit (ABK00751); KsKtzG, Kutzneria sp. kutzneride synthetase
G subunit (ABV56585); AfPSES, A. fumigatus pseurotin A synthetase (ABS87601); CpEALS, Claviceps purpurea ergot alkaloid synthetase (O94205);
AfGliP, A. fumigatus gliotoxin synthetase (ABE60889); FsESYN, F. sambucinum enniatin synthetase (CAA88634). Bacterial Phe signature according to
Stachelhaus et al. (1999); fungal D-Hiv signature as described in the text.
b A-domain specificities: D-Hiv, D-2-hydroxyisovalerate; Kiv, 2-ketoisovalerate; V(LI), valine preferred, leucine and isoleucine accepted; I(LV), isoleu-
cine preferred, leucine and valine accepted.
c Numbering according to PheA (Challis et al., 2000; Stachelhaus et al., 1999). Specificity signatures were derived by NRPSpredictor (Rausch et al.,
2005).Stachelhaus et al., 1999). Prediction of substrate specificity is,
however, not currently possible in fungal NRPSs. The fungal
‘‘code,’’ if such exists, seems to be divergent from the one
used by bacteria, and deriving new correlations is hindered by
the scarcity of fungal A domains with known substrate specific-
ities (Schwarzer et al., 2003; von Do¨hren, 2004). We have used
the support vector machine-based program NRPSpredictor
(Rausch et al., 2005) to extract the 10 amino acid signatures of
the fungal CODSs (Table 2). Replacement by Gly, Ala, Val, or
Asn of the highly conserved Asp230 that anchors the substrate
amines is a hallmark of A domains recognizing non-amino acid
substrates (Schwarzer et al., 2003). Accordingly, Gly is featured
at this position in all the D-Hiv-activating A1 domains. The A1 do-
main signatures of these synthetases are highly similar to each
other (Table 2). The derived consensus signature, GALx(I/V)
VG(S/T)IK, represents to our knowledge for the first time a fun-
gal A-domain ‘‘codon’’ for the 2-hydroxycarboxylate precursor
D-Hiv. No significant similarity of this fungal D-Hiv signature is
evident with that of the 2-ketoisovalerate-activating A domains
of bacterial depsipeptide NRPSs (Fujimori et al., 2007; Magarvey
et al., 2006) (Table 2).
A comparison of the A2 domain specificity signature of
BbBEASwith the bacterial Phe code was unproductive (Table 2).
Comparison with the derived signatures of the three currently
identified fungal A domains that activate Phe was also equivocal.904 Chemistry & Biology 15, 898–907, September 22, 2008 ª2008 EWhereas the signature for the Phe-activating A domain of the As-
pergillus fumigatus pseurotin synthetase is rather similar to that
of BbBEAS, the signature of the gliotoxin synthetase from the
same Aspergillus species is highly different. This discrepancy
might indicate the existence of synonymous nonribosomal ‘‘co-
dons’’ for Phe activation in fungi: similar degeneracy was also
noted in the prokaryotic nonribosomal code (Schwarzer et al.,
2003; von Do¨hren, 2004). Surprisingly, the BbBEAS A2 domain
signature is very similar to those of the Leu-activating A2 domains
from the two identified bassianolide synthetases. This similarity
did not extend to the branched-chain amino acid activating A2
domains of the enniatin synthetases from two Fusarium sp. It
has been observed that A domains within a single biosynthetic
pathway are often very similar to each other in spite of activating
different amino acids (Wenzel et al., 2006). If nature switches
amino acid specificity by initially mutating the ‘‘codon’’ residues
only, then specificity signatures of orthologous A domains might
only be minimally altered to accommodate a new substrate. The
resulting convergent evolutionwould lead to a higher degeneracy
of the code and might confound a priori predictions. Alteration of
substrate specificity by such ‘‘keyhole surgery’’ has been demon-
strated in the lab (Finking and Marahiel, 2004).
In spite of formidable technical difficulties, heterologous pro-
duction of secondary metabolites is increasingly feasible (Halo
et al., 2008; Zirkle et al., 2004). Fungal PKSs, NRPSs, and evenlsevier Ltd All rights reserved
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pergillus hosts with the concomitant production of the corre-
sponding metabolites (Halo et al., 2008). Although production
of dissected NRPS domains in bacterial hosts is practicable
(Haese et al., 1994), in vivo production of fungal nonribosomal
peptide natural products in bacterial hosts is less straightfor-
ward. As an alternative, in vitro reconstitution of fungal nonribo-
somal peptide biosynthesis using recombinant enzymes of up to
236 kDa has been demonstrated (Balibar andWalsh, 2006). Here
we demonstrate the highly efficient in vivo production of beau-
vericin in a biocatalytic process using a recombinant E. coli strain
for the expression of the bbBeas gene encoding the 3189 amino
acid, 351.9 kDa beauvericin synthetase (Figure 4). Supplementa-
tion of the bioconversion reactions with D-Hiv was essential. Fur-
ther improvements in beauvericin production could be realized
with an E. coli host strain that facilitates protein folding; cultiva-
tion at a reduced temperature during protein expression; and
supplementation with L-Phe during an extended bioconversion
reaction (Figure 4). Remarkably, beauvericin titers in E. coli bio-
conversions reached about 40% of that from fermentations with
the native producer fungus, with a shortened process time
(3 days for E. coli versus 5–7 days for B. bassiana). To the best
of our knowledge, this is the first example of the production of
a fungal cyclooligomer depsipeptide in a surrogate host.
The physiological roles of natural products in their producer
organisms are surprisingly unclear (Turgeon et al., 2008). Al-
though a few fungal host-selective toxins have been shown to
contribute to pathogenesis, these represent only a tiny portion
of the astonishingly large deduced secondary metabolome
‘‘encoded’’ in fungal genomes (Turgeon et al., 2008). Systematic
inactivation of PKS or NRPS genes in fungi with sequenced ge-
nomes often reveals only a limited role of these metabolites in
pathogenicity (Turgeon et al., 2008). Thus, engineered F. avena-
ceum strains that do not produce enniatin were shown to be less
virulent, but production of enniatin did not correlate with viru-
lence in a wider panel of Fusarium strains (Herrmann et al.,
1996). Investigations into the virulence factors of the insect path-
ogen B. bassiana focused on lytic enzymes that provide entry
into the insect host by degrading the cuticle (Fan et al., 2007).
In addition to these enzymes, B. bassiana also produces varied
secondary metabolites (Figure 1). Among these, tenellin was
shown to have no significant role in insect pathogenesis (Eley
et al., 2007). We have recently demonstrated that the virulence
of a bassianolide-nonproducer B. bassiana strain is severely
compromised (unpublished data). By contrast, up to now the
in vivo role of beauvericin in entomopathogenesis has been con-
troversial. Beauvericin has been isolated from silkworm larvae
killed by B. bassiana (Kwon et al., 2000), showing that its biosyn-
thesis coincides with infection. Isolated beauvericin was toxic to
a Spodoptera cell line (Fornelli et al., 2004), but was apparently
well tolerated by H. zea (Champlin and Grula, 1979). Here we
compared the virulence of wild-type B. bassiana with that of
two near-isogenic mutant strains against three insects with
reportedly different sensitivities to beauvericin, and monitored
insect survival upon a fungal challenge at three different doses
(Figure 5). Whereas the beauvericin-nonproducer strain re-
mained marginally infectious, its virulence was severely reduced
in all three insect models, including H. zea which was previously
described as insensitive to synthetic beauvericin (Champlin andChemistry & Biology 15, 898–9Grula, 1979). A B. bassiana strain that is deficient in both beau-
vericin and bassianolide production was similarly compromised
in its virulence. However, it did not suffer an increased handicap
in pathogenicity compared to the bbBeas KO strain in any of the
insect models (Figure 5), suggesting that the contribution of
these two cyclodepsipeptides to B. bassiana virulence is not
additive. Herein we propose that beauvericin is a significantly
contributing, albeit not indispensable, factor for the virulence of
B. bassiana against its large variety of insect hosts. However,
the physiological roles of beauvericin, and the other secondary
metabolites of B. bassiana, are likely to be multifaceted. In natu-
ral settings, B. bassiana has to protect the insect cadaver as a
nutrient source against invasion by other competing pathogens
and saprophytes. Moreover, B. bassiana can also adopt sapro-
phytic, endophytic, or rhizosphere colonizer lifestyles that might
demand a secondary metabolome with divergent biotic effector
and abiotic stress mitigator activities (Turgeon et al., 2008).
SIGNIFICANCE
Fungal cyclooligomer depsipeptides exhibit potent antibi-
otic, antifungal, herbicidal, insecticidal, and nematicidal
activities, and inhibit multidrug resistance, cancer cell pro-
liferation, and cell motility. These metabolites are biosyn-
thesized by nonribosomal peptide synthetases (NRPSs)
that use highly unconventional biosynthetic mechanisms.
The identification of the beauvericin synthetase-encoding
bbBeas gene from the entomopathogen Beauveria bassiana
allowed us to generalize a proposed reaction sequence for
fungal cyclodepsipeptide biosynthesis. This includes the
programmed iterative use ofmodules for the assembly of di-
peptidol monomers from amino acid and hydroxycarboxylic
acid precursors, and the use of these monomers in a recur-
sive, inter- and intramolecular ester bond-forming oligomer-
ization and cyclization process supported by twin thiolation
and unusual N- and C-terminal condensation domains.
Comparison of fungal and bacterial pathways for the pro-
duction and activation of hydroxycarboxylate precursors,
and those for the cyclooligomerization of the peptidolmono-
mers, showed evidence of convergent evolution. Compara-
tive sequence analysis of adenylation domains revealed
a fungal specificity signature for D-2-hydroxyisovalerate
(D-Hiv). Heterologous expression of the bbBeas gene in
E. coli to produce the 351.9 kDa beauvericin synthetase
demonstrated, to our knowledge for the first time, the feasi-
bility of the heterologous in vivo production of a fully elabo-
rated fungal cyclooligomer depsipeptide. Comparative
insect infection assays using a beauvericin-nonproducer
B. bassiana strain, created by targeted gene disruption, re-
vealed that beauvericin is a bona fide virulence factor that
plays a significant albeit not indispensable role in entomo-
pathogenesis. These results will facilitate the deciphering
of the mechanistic details of cyclooligomer depsipeptide
biosynthesis in fungi, and enable the use of combinatorial
biosynthesis for the production of novel cyclodepsipeptide
unnatural natural products. The unambiguous identification
of a fungal secondary metabolite as an important virulence
factor contributes to our understanding of the ecological
role of these metabolites.07, September 22, 2008 ª2008 Elsevier Ltd All rights reserved 905
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Strains and Culture Conditions
B. bassiana ATCC 7159 was maintained on potato dextrose agar (PDA). E. coli
Epi300 and fosmid pCCFOS1 (Epicenter) were used for B. bassiana genomic
library construction, E. coli DH10B and plasmid pJET1 (Fermentas) served
for routine cloning and sequencing, and E. coli strains BL21(DE3) and Origami
B(DE3) with plasmid pACYCDuet-1 (Novagen) were utilized for heterologous
expression. Agrobacterium tumefaciens LBA4404 (Invitrogen) with the
plasmid pAg1-H3 (Zhang et al., 2003) and the bar (glufosinate resistance)
selectable marker gene from pCB1635 (Sweigard et al., 1997) were used for
Beauveria transformation.
PCR, Genomic Library Construction, and Screening
A-domain-homologous sequences were amplified from B. bassiana using four
different primer pairs as described in Supplemental Data available online.
RT-PCR was used to confirm the presence of transcripts with A-domain-
homologous sequences as described in Supplemental Data. To generate a
fosmid library with the CopyControl Fosmid Library Production kit (Epicenter),
B. bassiana genomic DNA was physically sheared and the 40 kb fraction was
isolated by pulsed-field gel electrophoresis. Clones (3456) of this library were
arrayed in microtiter plates for 3.53 coverage of the genome, and used for
colony hybridizations with the digoxigenin-labeled (Roche Applied Science)
PCR products EA1046 and separately EA1042.
Sequencing and Sequence Analysis
Double-stranded DNA templates for sequencing were generated in pJET1 by
cloning fragments of2 kb from partial HaeIII digests of fosmids fBbass28A03
and fBbass11F05. DNA sequencing was done at the University of Arizona Ge-
nomic Analysis and Core Technology facility. Sequencher 4.7 (Gene Codes)
and the VectorNTI suite 9.0 (Invitrogen) were used for sequence assembly
and analysis. FGENESH (Softberry) was used to build HMM-based gene
models with the F. graminearum training set. Gene models were manually cu-
rated using exon/intron boundary predictions from SPLICEVIEW (http://zeus2.
itb.cnr.it/webgene/wwwspliceview.html/) and multiple sequence align-
ments. The UMA algorithm was used for the prediction of domain boundaries
in NRPSs (Udwary et al., 2002).
Disruption of the bbBeas Gene
The disruption cassette (see Supplemental Data) contained the bar selectable
marker cloned in between two PCR-amplified DNA fragments covering the 50
and 30 regions of the bbBeas gene. This disruption cassette was used forAgro-
bacterium-mediated transformation as described (Eley et al., 2007; Fang et al.,
2004). Genomic DNA isolated from glufosinate-resistant B. bassiana trans-
formants was used for Southern hybridizations with the digoxigenin-labeled
(Roche Applied Science) bar gene as the probe. Three ectopic integrant and
three homologous replacement isolates each were evaluated independently
for beauvericin and bassianolide production by fermentation (Xu et al., 2007).
Heterologous Production of Beauvericin
The pACYC-bbBeas-sfp expression construct was based on pACYCDuet-1
and assembled as described in Supplemental Data. Starter cultures of E. coli
BL21(DE3) or Origami B(DE3)-based expression strains were grown over-
night at 37C in LBmedium (3ml) with shaking at 250 rpm.Main-stage cultures
(200 ml, LB medium) were grown at 37C with shaking at 250 rpm to an OD600
of 1.0, and transferred to 16C for induction with IPTG (200 mM, final concen-
tration). Incubation with shaking at 250 rpm was continued for 16 hr at 16C.
Chloramphenicol (12.5 mg/ml, final concentration) was supplemented to all cul-
tures. The cells were collected by centrifugation, and resuspended in fresh LB
medium (20ml) supplemented with D-Hiv and L-Phe (each at 15mM, final con-
centrations). The resultant biotransformation reactions were incubated with
shaking at 250 rpm for 48 hr at 16C.
Extraction and Analysis of Beauvericin
Beauvericin was extracted from B. bassiana and E. coli fermentations and an-
alyzed by HPLC as described (Xu et al., 2007). Accurate mass measurements
were done on a Bruker Apex 9.4T FTICR-MS instrument with electrospray ion-
ization to generate the singly charged ions. Beauvericin isolated from E. coli906 Chemistry & Biology 15, 898–907, September 22, 2008 ª2008 Ebiocatalytic reactions, m/z: [M+H]+ C45H58N3O9, calculated 784.4168, mea-
sured 784.4181; [M+Na]+ C45H57N3O9Na, calculated 806.3987, measured
806.4003; [M+K]+ C45H57N3O9K, calculated 822.3736, measured 822.3739.
Insect Pathogenesis Assays
Aerial conidia were harvested in Triton X-100 (0.05%) from B. bassiana strains
grown on PDA plates at 28C for 14 days, and filtered through a 100 mmmesh
size cell strainer (BD Falcon). Conidial concentrations were adjusted to 101,
103, and 106 conidia/ml using a hemocytometer. Conidia viability was as-
sessed by outgrowth on PDA plates. Germination rates ranged from 90% to
100%. Last-instar larvae of G. mellonella (Timberline Fisheries), H. zea, and
S. exigua (both from Benzon Research) were inoculated by immersion in 10
ml conidial suspensions for 10 s, and transferred individually into the wells of
a 12-well plate that contained one filter paper disc (Whatman no. 1).Well plates
were incubated at 20C with a 16:8 hr photoperiod under humid conditions.
Controls consisted of larvae treated with water only. Ten larvae of each insect
species were used for each B. bassiana strain at each inoculum concentration,
and the experiments were repeated twice. The larvae were checked for mor-
tality daily for 7 days. Data were analyzed using SigmaStat 3.5 (Systat Soft-
ware) for analysis of variance (ANOVA) with the Student-Newman-Keuls test
to compare means, and correcting for control mortality with Abbott’s formula.
ACCESSION NUMBERS
The sequence of the beauvericin locus has been deposited in GenBank under
accession number EU886196.
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